| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 675,3 M € | +8.1% | 624,7 M € | +5.1% | 594,4 M € | +6.8% | 556,5 M € | +12.8% | 493,2 M € | +11.4% | 442,8 M € | +17.8% | 376,0 M € | +30.7% | 287,8 M € | +30.0% | 221,4 M € | +15.3% | 192,1 M € | -2.8% | 197,6 M € | +18.6% | 166,6 M € | +10.5% | 150,7 M € | +8.9% | 138,5 M € | +10.5% | 125,3 M € | +7.0% | 117,1 M € | -5.6% | 124,1 M € | +4.0% | 119,3 M € | -25.1% | 159,4 M € | -10.2% | 177,4 M € | |
| EBITDA | 37,7 M € | +84.5% | 20,4 M € | -25.6% | 27,4 M € | +56.4% | 17,5 M € | -35.4% | 27,2 M € | -7.4% | 29,3 M € | +47.2% | 19,9 M € | +42.7% | 14,0 M € | +89.8% | 7,4 M € | -7.4% | 7,9 M € | +26.1% | 6,3 M € | +6.2% | 5,9 M € | +49.0% | 4,0 M € | -32.2% | 5,9 M € | -11.4% | 6,6 M € | -0.4% | 6,7 M € | +4.3% | 6,4 M € | -5.1% | 6,7 M € | +46.0% | 4,6 M € | -18.8% | 5,7 M € | |
| Operating profit | 39,5 M € | +125.2% | 17,6 M € | -35.3% | 27,1 M € | +59.7% | 17,0 M € | -37.1% | 27,0 M € | -7.6% | 29,2 M € | +48.0% | 19,7 M € | +41.3% | 14,0 M € | +100.5% | 7,0 M € | -12.3% | 7,9 M € | +26.5% | 6,3 M € | +19.8% | 5,2 M € | +41.0% | 3,7 M € | -32.4% | 5,5 M € | -11.9% | 6,2 M € | +2.1% | 6,1 M € | +4.6% | 5,8 M € | +1.1% | 5,8 M € | +54.9% | 3,7 M € | -26.2% | 5,1 M € | |
| Profit/loss | 30,9 M € | +106.0% | 15,0 M € | -28.4% | 20,9 M € | +64.0% | 12,7 M € | -36.8% | 20,2 M € | -2.9% | 20,8 M € | +53.4% | 13,5 M € | +29.9% | 10,4 M € | +140.1% | 4,3 M € | -8.9% | 4,8 M € | +8.3% | 4,4 M € | -78.4% | 20,4 M € | -24.6% | 27,0 M € | +519.0% | 4,4 M € | +62.3% | 2,7 M € | -33.1% | 4,0 M € | +110.7% | 1,9 M € | -43.3% | 3,4 M € | +13.9% | 3,0 M € | -15.3% | 3,5 M € | |
| Equity | 101,3 M € | +25.9% | 80,4 M € | +22.9% | 65,5 M € | +46.9% | 44,6 M € | -18.7% | 54,8 M € | +17.5% | 46,6 M € | +20.0% | 38,9 M € | -55.4% | 87,1 M € | +13.6% | 76,6 M € | +6.0% | 72,3 M € | +7.1% | 67,5 M € | +7.0% | 63,1 M € | +10.2% | 57,3 M € | +37.7% | 41,6 M € | +11.7% | 37,2 M € | +7.8% | 34,5 M € | +9.1% | 31,6 M € | +6.4% | 29,7 M € | +12.8% | 26,4 M € | +12.6% | 23,4 M € | |
| Total assets | 188,0 M € | -3.9% | 195,7 M € | -3.0% | 201,6 M € | +39.9% | 144,1 M € | +7.3% | 134,3 M € | -5.5% | 142,1 M € | +21.5% | 116,9 M € | -31.0% | 169,5 M € | +15.6% | 146,6 M € | +2.5% | 142,9 M € | -1.6% | 145,3 M € | +15.5% | 125,7 M € | +3.9% | 121,0 M € | +36.2% | 88,9 M € | +4.2% | 85,3 M € | +0.6% | 84,8 M € | -15.0% | 99,8 M € | +19.7% | 83,4 M € | +43.2% | 58,2 M € | +9.3% | 53,3 M € | |
| Cash | 7,3 M € | +28.7% | 5,7 M € | -6.9% | 6,1 M € | -42.1% | 10,6 M € | +17.5% | 9,0 M € | +14.6% | 7,9 M € | +63.0% | 4,8 M € | -64.6% | 13,6 M € | -86.6% | 101,2 M € | +5553.5% | 1,8 M € | -27.4% | 2,5 M € | +70.1% | 1,4 M € | -43.5% | 2,6 M € | +55.9% | 1,6 M € | -25.8% | 2,2 M € | -9.7% | 2,5 M € | -21.7% | 3,1 M € | -92.3% | 41,0 M € | +205.1% | 13,4 M € | +182.4% | 4,8 M € | |
| Debts | 74,0 M € | -27.5% | 102,2 M € | -20.3% | 128,3 M € | +40.3% | 91,4 M € | +27.9% | 71,5 M € | -18.2% | 87,4 M € | +25.4% | 69,7 M € | -8.6% | 76,2 M € | +22.4% | 62,3 M € | +0.6% | 61,9 M € | -8.2% | 67,4 M € | +41.0% | 47,8 M € | -8.7% | 52,4 M € | +58.1% | 33,1 M € | +5.2% | 31,5 M € | -25.4% | 42,3 M € | -24.6% | 56,0 M € | +64.3% | 34,1 M € | +15.0% | 29,7 M € | +11.6% | 26,6 M € | |
| Staff | 207,6 | 216,1 | 230,4 | 238,5 | 217,6 | 200 | 192,3 | 164,2 | 151,8 | 166,8 | 163,8 | 154,4 | 175 | 179,5 | 175,1 | 173,4 | 192,1 | 191,9 | 215,5 | 240,2 | ||||||||||||||||||||
Public limited company · Beerse · incorporated on 06/08/1975 · 207,6 ETP
Public limited company profitable and well capitalised. Cash position rising (+28.7%).
Solid counterparty for a standard engagement.
Janssen-Cilag is a Public limited company incorporated in 1975. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Beerse. It employs on average 207,6 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette